A Phase 1b/2 Trial of AMG 386 in Combination with Pemetr

Project: Research project

Project Details

Description

A Phase 1b/2 Trial of AMG 386 in Combination with Pemetrexed and Carboplatin as First Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
StatusFinished
Effective start/end date6/1/133/31/14

Funding

  • Amgen Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.